There is also in vivo data on the implication of ECM-degrading enzymes in incontinence, as increased MMP-2 and MMP-9 activity was reported in the vaginal wall after VD (Rahn et al., 2008). The gene discussed is MMP2; the disease is Urinary incontinence.